A carregar...
No Benefit of Continuing versus Stopping 5-Aminosalicylates in Patients with Ulcerative Colitis Escalated to Anti-metabolite Therapy
BACKGROUND: Whilst continuation of 5-aminosalicylates (5-ASA) after escalation to biologic therapy is considered ineffective in patients with ulcerative colitis (UC), their role in patients escalated to anti-metabolites is unclear. AIMS: We compared patterns and outcomes of continuing versus stoppin...
Na minha lista:
| Publicado no: | Aliment Pharmacol Ther |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8015755/ https://ncbi.nlm.nih.gov/pubmed/32573825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15876 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|